Falcone, Marco
Bassetti, Matteo
Tiseo, Giusy
Giordano, Cesira
Nencini, Elia
Russo, Alessandro
Graziano, Elena
Tagliaferri, Enrico
Leonildi, Alessandro
Barnini, Simona
Farcomeni, Alessio
Menichetti, Francesco
Funding for this research was provided by:
Shionogi (only for writing)
Article History
Received: 1 November 2019
Accepted: 14 January 2020
First Online: 30 January 2020
Ethics approval and consent to participate
: Local ethical committee (CEAVNO) approved the study.
: Not applicable.
: MF received grants and was speaker honoraria for MSD, Angelini, Shionogi. FM has participated in advisory boards and/or received speaker honoraria from Angelini, Correvio, MSD, Pfizer, Astellas, Gilead, BMS, Jansenn, ViiV, BioMerieux, Biotest, Becton-Dickinson, Nordic Pharma, Pfizer, Shionogi. MB has participated in advisory boards and/or received speaker honoraria from Achaogen, Angelini, Astellas, AstraZeneca, Bayer, Basilea, Biomerieux, Cepheid, Cidara, Gilead, Menarini, MSD, Paratek, Pfizer, Roche, The Medicine Company, Shionogi, Tetraphase, VenatoRx and Vifor. The remaining authors declare that they have no competing interests.